Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
MTUS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
PRTG - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CREG2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BHLHE41 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
KIAA0141 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GSTM2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
POMGNT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NAP1L4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ACACB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NBEAP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRSS22 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NSMAF - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GRIA4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CSNK1A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC284939 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SOX6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on